NEW YORK (GenomeWeb News) — Motif Biosciences has raised $1 million in series C financing to help pay for research into type 2 diabetes and asthma, partner company Amphion Innovations said today.
 
Amphion, which owns 47 percent of Motif, said it was responsible for $400,000 of the financing round.
 
in March, Motif reported receiving $1.8 million in financing, of which $500,000 came from Amphion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.